BSTM-04. NEURONAL-ACTIVITY SECRETED BDNF INCREASES DIPG PROLIFERATION. Article Swipe
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1093/neuonc/noz036.021
Pediatric high-grade gliomas (pHGG) are a devastating group of diseases that critically require novel therapeutic options. We have previously demonstrated that pHGG hijacks mechanisms of brain development and plasticity to their advantage. One key process, neuronal activity, robustly drives proliferation of pHGG via the secretion of the synaptic protein neuroligin-3 (NLGN3) and the neurotrophin brain-derived neurotrophic factor (BDNF) into the tumor microenvironment. Diffuse intrinsic pontine gliomas (DIPG) exhibit copy-number gain of neurotrophin receptor genes in a substantial fraction of cases (71/239, 29% cases with NTRK1, NTRK2 or NTRK3 gain/amplification), and primary DIPG tumor RNA-Seq confirms expression of the canonical BDNF receptor TrkB. Here, we investigated the role of microenvironmental BDNF on DIPG, independent of the NTRK fusion events commonly identified in infant HGG. We found spatio-temporal patterns of BDNF expression in normal brain during the postnatal developmental period that highlight this growth factor as particularly relevant to childhood gliomas. Conditioned media (CM) collected from optogenetically stimulated acute cortical slices robustly increases patient-derived DIPG cell proliferation, an effect that is abrogated with CM collected from mice deficient of activity-regulated BDNF expression. The BDNF ligand increases patient-derived DIPG cell proliferation and activates the canonical downstream MAPK signaling pathway. CRISPR deletion of the TrkB receptor, NTRK2, in DIPG cells abrogates the proliferative response to BDNF ligand exposure and subsequent p42/44 MAPK pathway activation. We are currently testing the in vivo growth potential of TrkB-deficient DIPG xenografts and the therapeutic potential of pharmacological TrkB antagonists. Disrupting DIPG responses to microenvironmental cues may highlight tumor dependencies and elucidate effective combinatorial therapeutic strategies. Funding: Abbie’s Army Foundation
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1093/neuonc/noz036.021
- https://academic.oup.com/neuro-oncology/article-pdf/21/Supplement_2/ii67/28443372/noz036.021.pdf
- OA Status
- bronze
- Cited By
- 1
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2941450039
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2941450039Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1093/neuonc/noz036.021Digital Object Identifier
- Title
-
BSTM-04. NEURONAL-ACTIVITY SECRETED BDNF INCREASES DIPG PROLIFERATION.Work title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2019Year of publication
- Publication date
-
2019-04-01Full publication date if available
- Authors
-
Kathryn Taylor, Razina Aziz‐Bose, Ariane Blank, Anna C. Geraghty, Michelle MonjeList of authors in order
- Landing page
-
https://doi.org/10.1093/neuonc/noz036.021Publisher landing page
- PDF URL
-
https://academic.oup.com/neuro-oncology/article-pdf/21/Supplement_2/ii67/28443372/noz036.021.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://academic.oup.com/neuro-oncology/article-pdf/21/Supplement_2/ii67/28443372/noz036.021.pdfDirect OA link when available
- Concepts
-
Tropomyosin receptor kinase B, Neurotrophic factors, Brain-derived neurotrophic factor, MAPK/ERK pathway, Neurotrophin, Biology, Trk receptor, Cancer research, Neuroscience, Receptor, Internal medicine, Cell biology, Signal transduction, Medicine, GeneticsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
1Total citation count in OpenAlex
- Citations by year (recent)
-
2020: 1Per-year citation counts (last 5 years)
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2941450039 |
|---|---|
| doi | https://doi.org/10.1093/neuonc/noz036.021 |
| ids.doi | https://doi.org/10.1093/neuonc/noz036.021 |
| ids.mag | 2941450039 |
| ids.openalex | https://openalex.org/W2941450039 |
| fwci | 0.18610493 |
| type | article |
| title | BSTM-04. NEURONAL-ACTIVITY SECRETED BDNF INCREASES DIPG PROLIFERATION. |
| biblio.issue | Supplement_2 |
| biblio.volume | 21 |
| biblio.last_page | ii68 |
| biblio.first_page | ii67 |
| topics[0].id | https://openalex.org/T10129 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9650999903678894 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2716 |
| topics[0].subfield.display_name | Genetics |
| topics[0].display_name | Glioma Diagnosis and Treatment |
| topics[1].id | https://openalex.org/T12226 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9273999929428101 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2728 |
| topics[1].subfield.display_name | Neurology |
| topics[1].display_name | Neuroblastoma Research and Treatments |
| is_xpac | False |
| apc_list.value | 4612 |
| apc_list.currency | USD |
| apc_list.value_usd | 4612 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C97124661 |
| concepts[0].level | 4 |
| concepts[0].score | 0.8914304971694946 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q14897782 |
| concepts[0].display_name | Tropomyosin receptor kinase B |
| concepts[1].id | https://openalex.org/C160539049 |
| concepts[1].level | 3 |
| concepts[1].score | 0.6678277254104614 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q3064187 |
| concepts[1].display_name | Neurotrophic factors |
| concepts[2].id | https://openalex.org/C2778790584 |
| concepts[2].level | 4 |
| concepts[2].score | 0.6550902128219604 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q123045 |
| concepts[2].display_name | Brain-derived neurotrophic factor |
| concepts[3].id | https://openalex.org/C57074206 |
| concepts[3].level | 3 |
| concepts[3].score | 0.5755113363265991 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q14197552 |
| concepts[3].display_name | MAPK/ERK pathway |
| concepts[4].id | https://openalex.org/C92020748 |
| concepts[4].level | 3 |
| concepts[4].score | 0.5489556789398193 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q420457 |
| concepts[4].display_name | Neurotrophin |
| concepts[5].id | https://openalex.org/C86803240 |
| concepts[5].level | 0 |
| concepts[5].score | 0.527235209941864 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[5].display_name | Biology |
| concepts[6].id | https://openalex.org/C134139212 |
| concepts[6].level | 4 |
| concepts[6].score | 0.4897144138813019 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q24719927 |
| concepts[6].display_name | Trk receptor |
| concepts[7].id | https://openalex.org/C502942594 |
| concepts[7].level | 1 |
| concepts[7].score | 0.4782649278640747 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[7].display_name | Cancer research |
| concepts[8].id | https://openalex.org/C169760540 |
| concepts[8].level | 1 |
| concepts[8].score | 0.4064050018787384 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q207011 |
| concepts[8].display_name | Neuroscience |
| concepts[9].id | https://openalex.org/C170493617 |
| concepts[9].level | 2 |
| concepts[9].score | 0.3733375072479248 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q208467 |
| concepts[9].display_name | Receptor |
| concepts[10].id | https://openalex.org/C126322002 |
| concepts[10].level | 1 |
| concepts[10].score | 0.32658639550209045 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[10].display_name | Internal medicine |
| concepts[11].id | https://openalex.org/C95444343 |
| concepts[11].level | 1 |
| concepts[11].score | 0.316872775554657 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7141 |
| concepts[11].display_name | Cell biology |
| concepts[12].id | https://openalex.org/C62478195 |
| concepts[12].level | 2 |
| concepts[12].score | 0.3135014772415161 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q828130 |
| concepts[12].display_name | Signal transduction |
| concepts[13].id | https://openalex.org/C71924100 |
| concepts[13].level | 0 |
| concepts[13].score | 0.2529495358467102 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[13].display_name | Medicine |
| concepts[14].id | https://openalex.org/C54355233 |
| concepts[14].level | 1 |
| concepts[14].score | 0.10603582859039307 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[14].display_name | Genetics |
| keywords[0].id | https://openalex.org/keywords/tropomyosin-receptor-kinase-b |
| keywords[0].score | 0.8914304971694946 |
| keywords[0].display_name | Tropomyosin receptor kinase B |
| keywords[1].id | https://openalex.org/keywords/neurotrophic-factors |
| keywords[1].score | 0.6678277254104614 |
| keywords[1].display_name | Neurotrophic factors |
| keywords[2].id | https://openalex.org/keywords/brain-derived-neurotrophic-factor |
| keywords[2].score | 0.6550902128219604 |
| keywords[2].display_name | Brain-derived neurotrophic factor |
| keywords[3].id | https://openalex.org/keywords/mapk/erk-pathway |
| keywords[3].score | 0.5755113363265991 |
| keywords[3].display_name | MAPK/ERK pathway |
| keywords[4].id | https://openalex.org/keywords/neurotrophin |
| keywords[4].score | 0.5489556789398193 |
| keywords[4].display_name | Neurotrophin |
| keywords[5].id | https://openalex.org/keywords/biology |
| keywords[5].score | 0.527235209941864 |
| keywords[5].display_name | Biology |
| keywords[6].id | https://openalex.org/keywords/trk-receptor |
| keywords[6].score | 0.4897144138813019 |
| keywords[6].display_name | Trk receptor |
| keywords[7].id | https://openalex.org/keywords/cancer-research |
| keywords[7].score | 0.4782649278640747 |
| keywords[7].display_name | Cancer research |
| keywords[8].id | https://openalex.org/keywords/neuroscience |
| keywords[8].score | 0.4064050018787384 |
| keywords[8].display_name | Neuroscience |
| keywords[9].id | https://openalex.org/keywords/receptor |
| keywords[9].score | 0.3733375072479248 |
| keywords[9].display_name | Receptor |
| keywords[10].id | https://openalex.org/keywords/internal-medicine |
| keywords[10].score | 0.32658639550209045 |
| keywords[10].display_name | Internal medicine |
| keywords[11].id | https://openalex.org/keywords/cell-biology |
| keywords[11].score | 0.316872775554657 |
| keywords[11].display_name | Cell biology |
| keywords[12].id | https://openalex.org/keywords/signal-transduction |
| keywords[12].score | 0.3135014772415161 |
| keywords[12].display_name | Signal transduction |
| keywords[13].id | https://openalex.org/keywords/medicine |
| keywords[13].score | 0.2529495358467102 |
| keywords[13].display_name | Medicine |
| keywords[14].id | https://openalex.org/keywords/genetics |
| keywords[14].score | 0.10603582859039307 |
| keywords[14].display_name | Genetics |
| language | en |
| locations[0].id | doi:10.1093/neuonc/noz036.021 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S106908163 |
| locations[0].source.issn | 1522-8517, 1523-5866 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1522-8517 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Neuro-Oncology |
| locations[0].source.host_organization | https://openalex.org/P4310311648 |
| locations[0].source.host_organization_name | Oxford University Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310311648 |
| locations[0].license | |
| locations[0].pdf_url | https://academic.oup.com/neuro-oncology/article-pdf/21/Supplement_2/ii67/28443372/noz036.021.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Neuro-Oncology |
| locations[0].landing_page_url | https://doi.org/10.1093/neuonc/noz036.021 |
| locations[1].id | pmh:oai:pubmedcentral.nih.gov:6477415 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S2764455111 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed Central |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | Neuro Oncol |
| locations[1].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/6477415 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5069680011 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-1889-3188 |
| authorships[0].author.display_name | Kathryn Taylor |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I97018004 |
| authorships[0].affiliations[0].raw_affiliation_string | Stanford University, Stanford, CA, USA |
| authorships[0].institutions[0].id | https://openalex.org/I97018004 |
| authorships[0].institutions[0].ror | https://ror.org/00f54p054 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I97018004 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Stanford University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Kathryn Taylor |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Stanford University, Stanford, CA, USA |
| authorships[1].author.id | https://openalex.org/A5025134147 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Razina Aziz‐Bose |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I97018004 |
| authorships[1].affiliations[0].raw_affiliation_string | Stanford University, Stanford, CA, USA |
| authorships[1].institutions[0].id | https://openalex.org/I97018004 |
| authorships[1].institutions[0].ror | https://ror.org/00f54p054 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I97018004 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Stanford University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Razina Aziz-Bose |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Stanford University, Stanford, CA, USA |
| authorships[2].author.id | https://openalex.org/A5060800377 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-8652-2816 |
| authorships[2].author.display_name | Ariane Blank |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I97018004 |
| authorships[2].affiliations[0].raw_affiliation_string | Stanford University, Stanford, CA, USA |
| authorships[2].institutions[0].id | https://openalex.org/I97018004 |
| authorships[2].institutions[0].ror | https://ror.org/00f54p054 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I97018004 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Stanford University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Ariane Blank |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Stanford University, Stanford, CA, USA |
| authorships[3].author.id | https://openalex.org/A5089143531 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-5914-1412 |
| authorships[3].author.display_name | Anna C. Geraghty |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I97018004 |
| authorships[3].affiliations[0].raw_affiliation_string | Stanford University, Stanford, CA, USA |
| authorships[3].institutions[0].id | https://openalex.org/I97018004 |
| authorships[3].institutions[0].ror | https://ror.org/00f54p054 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I97018004 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Stanford University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Anna Geraghty |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Stanford University, Stanford, CA, USA |
| authorships[4].author.id | https://openalex.org/A5022800990 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-3547-237X |
| authorships[4].author.display_name | Michelle Monje |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I97018004 |
| authorships[4].affiliations[0].raw_affiliation_string | Stanford University, Stanford, CA, USA |
| authorships[4].institutions[0].id | https://openalex.org/I97018004 |
| authorships[4].institutions[0].ror | https://ror.org/00f54p054 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I97018004 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Stanford University |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | Michelle Monje |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Stanford University, Stanford, CA, USA |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://academic.oup.com/neuro-oncology/article-pdf/21/Supplement_2/ii67/28443372/noz036.021.pdf |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | BSTM-04. NEURONAL-ACTIVITY SECRETED BDNF INCREASES DIPG PROLIFERATION. |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10129 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9650999903678894 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2716 |
| primary_topic.subfield.display_name | Genetics |
| primary_topic.display_name | Glioma Diagnosis and Treatment |
| related_works | https://openalex.org/W56018094, https://openalex.org/W2090228900, https://openalex.org/W2087696642, https://openalex.org/W4383423954, https://openalex.org/W4280574736, https://openalex.org/W2024625433, https://openalex.org/W2103580807, https://openalex.org/W2588481612, https://openalex.org/W2033529533, https://openalex.org/W2118813298 |
| cited_by_count | 1 |
| counts_by_year[0].year | 2020 |
| counts_by_year[0].cited_by_count | 1 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1093/neuonc/noz036.021 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S106908163 |
| best_oa_location.source.issn | 1522-8517, 1523-5866 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1522-8517 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Neuro-Oncology |
| best_oa_location.source.host_organization | https://openalex.org/P4310311648 |
| best_oa_location.source.host_organization_name | Oxford University Press |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310311648 |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://academic.oup.com/neuro-oncology/article-pdf/21/Supplement_2/ii67/28443372/noz036.021.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Neuro-Oncology |
| best_oa_location.landing_page_url | https://doi.org/10.1093/neuonc/noz036.021 |
| primary_location.id | doi:10.1093/neuonc/noz036.021 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S106908163 |
| primary_location.source.issn | 1522-8517, 1523-5866 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1522-8517 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Neuro-Oncology |
| primary_location.source.host_organization | https://openalex.org/P4310311648 |
| primary_location.source.host_organization_name | Oxford University Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310311648 |
| primary_location.license | |
| primary_location.pdf_url | https://academic.oup.com/neuro-oncology/article-pdf/21/Supplement_2/ii67/28443372/noz036.021.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Neuro-Oncology |
| primary_location.landing_page_url | https://doi.org/10.1093/neuonc/noz036.021 |
| publication_date | 2019-04-01 |
| publication_year | 2019 |
| referenced_works_count | 0 |
| abstract_inverted_index.a | 5, 75 |
| abstract_inverted_index.CM | 171 |
| abstract_inverted_index.We | 16, 123, 220 |
| abstract_inverted_index.an | 165 |
| abstract_inverted_index.as | 143 |
| abstract_inverted_index.in | 74, 120, 130, 203, 225 |
| abstract_inverted_index.is | 168 |
| abstract_inverted_index.of | 8, 24, 40, 45, 70, 78, 96, 107, 113, 127, 176, 198, 229, 237 |
| abstract_inverted_index.on | 110 |
| abstract_inverted_index.or | 86 |
| abstract_inverted_index.to | 29, 146, 210, 244 |
| abstract_inverted_index.we | 103 |
| abstract_inverted_index.29% | 81 |
| abstract_inverted_index.One | 32 |
| abstract_inverted_index.The | 180 |
| abstract_inverted_index.and | 27, 51, 89, 188, 214, 233, 251 |
| abstract_inverted_index.are | 4, 221 |
| abstract_inverted_index.key | 33 |
| abstract_inverted_index.may | 247 |
| abstract_inverted_index.the | 43, 46, 52, 59, 97, 105, 114, 134, 190, 199, 207, 224, 234 |
| abstract_inverted_index.via | 42 |
| abstract_inverted_index.(CM) | 151 |
| abstract_inverted_index.Army | 259 |
| abstract_inverted_index.BDNF | 99, 109, 128, 178, 181, 211 |
| abstract_inverted_index.DIPG | 91, 162, 185, 204, 231, 242 |
| abstract_inverted_index.HGG. | 122 |
| abstract_inverted_index.MAPK | 193, 217 |
| abstract_inverted_index.NTRK | 115 |
| abstract_inverted_index.TrkB | 200, 239 |
| abstract_inverted_index.cell | 163, 186 |
| abstract_inverted_index.cues | 246 |
| abstract_inverted_index.from | 153, 173 |
| abstract_inverted_index.gain | 69 |
| abstract_inverted_index.have | 17 |
| abstract_inverted_index.into | 58 |
| abstract_inverted_index.mice | 174 |
| abstract_inverted_index.pHGG | 21, 41 |
| abstract_inverted_index.role | 106 |
| abstract_inverted_index.that | 10, 20, 138, 167 |
| abstract_inverted_index.this | 140 |
| abstract_inverted_index.vivo | 226 |
| abstract_inverted_index.with | 83, 170 |
| abstract_inverted_index.DIPG, | 111 |
| abstract_inverted_index.Here, | 102 |
| abstract_inverted_index.NTRK2 | 85 |
| abstract_inverted_index.NTRK3 | 87 |
| abstract_inverted_index.TrkB. | 101 |
| abstract_inverted_index.acute | 156 |
| abstract_inverted_index.brain | 25, 132 |
| abstract_inverted_index.cases | 79, 82 |
| abstract_inverted_index.cells | 205 |
| abstract_inverted_index.found | 124 |
| abstract_inverted_index.genes | 73 |
| abstract_inverted_index.group | 7 |
| abstract_inverted_index.media | 150 |
| abstract_inverted_index.novel | 13 |
| abstract_inverted_index.their | 30 |
| abstract_inverted_index.tumor | 60, 92, 249 |
| abstract_inverted_index.(BDNF) | 57 |
| abstract_inverted_index.(DIPG) | 66 |
| abstract_inverted_index.(pHGG) | 3 |
| abstract_inverted_index.CRISPR | 196 |
| abstract_inverted_index.NTRK1, | 84 |
| abstract_inverted_index.NTRK2, | 202 |
| abstract_inverted_index.drives | 38 |
| abstract_inverted_index.during | 133 |
| abstract_inverted_index.effect | 166 |
| abstract_inverted_index.events | 117 |
| abstract_inverted_index.factor | 56, 142 |
| abstract_inverted_index.fusion | 116 |
| abstract_inverted_index.growth | 141, 227 |
| abstract_inverted_index.infant | 121 |
| abstract_inverted_index.ligand | 182, 212 |
| abstract_inverted_index.normal | 131 |
| abstract_inverted_index.p42/44 | 216 |
| abstract_inverted_index.period | 137 |
| abstract_inverted_index.slices | 158 |
| abstract_inverted_index.(NLGN3) | 50 |
| abstract_inverted_index.Diffuse | 62 |
| abstract_inverted_index.RNA-Seq | 93 |
| abstract_inverted_index.exhibit | 67 |
| abstract_inverted_index.gliomas | 2, 65 |
| abstract_inverted_index.hijacks | 22 |
| abstract_inverted_index.pathway | 218 |
| abstract_inverted_index.pontine | 64 |
| abstract_inverted_index.primary | 90 |
| abstract_inverted_index.protein | 48 |
| abstract_inverted_index.require | 12 |
| abstract_inverted_index.testing | 223 |
| abstract_inverted_index.(71/239, | 80 |
| abstract_inverted_index.Funding: | 257 |
| abstract_inverted_index.commonly | 118 |
| abstract_inverted_index.confirms | 94 |
| abstract_inverted_index.cortical | 157 |
| abstract_inverted_index.deletion | 197 |
| abstract_inverted_index.diseases | 9 |
| abstract_inverted_index.exposure | 213 |
| abstract_inverted_index.fraction | 77 |
| abstract_inverted_index.gliomas. | 148 |
| abstract_inverted_index.neuronal | 35 |
| abstract_inverted_index.options. | 15 |
| abstract_inverted_index.pathway. | 195 |
| abstract_inverted_index.patterns | 126 |
| abstract_inverted_index.process, | 34 |
| abstract_inverted_index.receptor | 72, 100 |
| abstract_inverted_index.relevant | 145 |
| abstract_inverted_index.response | 209 |
| abstract_inverted_index.robustly | 37, 159 |
| abstract_inverted_index.synaptic | 47 |
| abstract_inverted_index.Abbie’s | 258 |
| abstract_inverted_index.Pediatric | 0 |
| abstract_inverted_index.abrogated | 169 |
| abstract_inverted_index.abrogates | 206 |
| abstract_inverted_index.activates | 189 |
| abstract_inverted_index.activity, | 36 |
| abstract_inverted_index.canonical | 98, 191 |
| abstract_inverted_index.childhood | 147 |
| abstract_inverted_index.collected | 152, 172 |
| abstract_inverted_index.currently | 222 |
| abstract_inverted_index.deficient | 175 |
| abstract_inverted_index.effective | 253 |
| abstract_inverted_index.elucidate | 252 |
| abstract_inverted_index.highlight | 139, 248 |
| abstract_inverted_index.increases | 160, 183 |
| abstract_inverted_index.intrinsic | 63 |
| abstract_inverted_index.postnatal | 135 |
| abstract_inverted_index.potential | 228, 236 |
| abstract_inverted_index.receptor, | 201 |
| abstract_inverted_index.responses | 243 |
| abstract_inverted_index.secretion | 44 |
| abstract_inverted_index.signaling | 194 |
| abstract_inverted_index.Disrupting | 241 |
| abstract_inverted_index.Foundation | 260 |
| abstract_inverted_index.advantage. | 31 |
| abstract_inverted_index.critically | 11 |
| abstract_inverted_index.downstream | 192 |
| abstract_inverted_index.expression | 95, 129 |
| abstract_inverted_index.high-grade | 1 |
| abstract_inverted_index.identified | 119 |
| abstract_inverted_index.mechanisms | 23 |
| abstract_inverted_index.plasticity | 28 |
| abstract_inverted_index.previously | 18 |
| abstract_inverted_index.stimulated | 155 |
| abstract_inverted_index.subsequent | 215 |
| abstract_inverted_index.xenografts | 232 |
| abstract_inverted_index.Conditioned | 149 |
| abstract_inverted_index.activation. | 219 |
| abstract_inverted_index.copy-number | 68 |
| abstract_inverted_index.devastating | 6 |
| abstract_inverted_index.development | 26 |
| abstract_inverted_index.expression. | 179 |
| abstract_inverted_index.independent | 112 |
| abstract_inverted_index.strategies. | 256 |
| abstract_inverted_index.substantial | 76 |
| abstract_inverted_index.therapeutic | 14, 235, 255 |
| abstract_inverted_index.antagonists. | 240 |
| abstract_inverted_index.demonstrated | 19 |
| abstract_inverted_index.dependencies | 250 |
| abstract_inverted_index.investigated | 104 |
| abstract_inverted_index.neuroligin-3 | 49 |
| abstract_inverted_index.neurotrophic | 55 |
| abstract_inverted_index.neurotrophin | 53, 71 |
| abstract_inverted_index.particularly | 144 |
| abstract_inverted_index.brain-derived | 54 |
| abstract_inverted_index.combinatorial | 254 |
| abstract_inverted_index.developmental | 136 |
| abstract_inverted_index.proliferation | 39, 187 |
| abstract_inverted_index.proliferative | 208 |
| abstract_inverted_index.TrkB-deficient | 230 |
| abstract_inverted_index.proliferation, | 164 |
| abstract_inverted_index.optogenetically | 154 |
| abstract_inverted_index.patient-derived | 161, 184 |
| abstract_inverted_index.pharmacological | 238 |
| abstract_inverted_index.spatio-temporal | 125 |
| abstract_inverted_index.microenvironment. | 61 |
| abstract_inverted_index.activity-regulated | 177 |
| abstract_inverted_index.microenvironmental | 108, 245 |
| abstract_inverted_index.gain/amplification), | 88 |
| cited_by_percentile_year.max | 94 |
| cited_by_percentile_year.min | 89 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 5 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/2 |
| sustainable_development_goals[0].score | 0.5400000214576721 |
| sustainable_development_goals[0].display_name | Zero hunger |
| citation_normalized_percentile.value | 0.50989495 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |